BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36069783)

  • 21. Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas.
    Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Hanzu F; Mora M; Vicente A; Blanco Carrera C; Miguel Novoa P; López García MDC; Lamas C; Manjón-Miguélez L; Del Castillo Tous M; Rodríguez de Vera P; Barahona San Millán R; Recasens M; Fernández-Ladreda MT; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Calatayud M
    J Hypertens; 2024 Feb; 42(2):252-259. PubMed ID: 37851004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Predictors of Prolonged Hypotension After Open Surgery for Pheochromocytomas and Paragangliomas.
    Kong H; Li N; Tian J; Li XY
    World J Surg; 2020 Nov; 44(11):3786-3794. PubMed ID: 32691105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma.
    Lopez C; Bima C; Bollati M; Bioletto F; Procopio M; Arata S; Candela DG; Beccuti G; Ghigo E; Maccario M; Parasiliti-Caprino M
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metastatic risk factors in pheochromocytoma/paraganglioma].
    Rebrova DV; Loginova OI; Vorobyev SL; Vorokhobina NV; Kozorezova ES; Indeykin FA; Savelyeva TV; Sleptsov IV; Chernikov RA; Fedorov EA; Semenov AA; Chinchuk IK; Shikhmagomedov SS; Alekseev MA; Krasnov LM; Rusakov VF
    Probl Endokrinol (Mosk); 2023 Oct; 70(2):37-45. PubMed ID: 38796759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative intravenous rehydration for patients with pheochromocytomas and paragangliomas: is it necessary? A propensity score matching analysis.
    Kong H; Yang JN; Tian J; Li N; Zhang YX; Ye PC; Li XY; Zhang Z
    BMC Anesthesiol; 2020 Nov; 20(1):294. PubMed ID: 33250060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pheochromocytoma and glucoregulation disorders.
    Derrou S; Bouziane T; Salhi H; El Ouahabi H
    Ann Afr Med; 2021; 20(1):42-45. PubMed ID: 33727511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study.
    Zhao L; Meng X; Mei Q; Fan H; Liu Y; Zhou X; Zhu H; Zhang S
    Front Endocrinol (Lausanne); 2022; 13():877341. PubMed ID: 35721724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pheochromocytoma/Paraganglioma: Review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma.
    Fishbein L; Orlowski R; Cohen D
    J Clin Hypertens (Greenwich); 2013 Jun; 15(6):428-34. PubMed ID: 23730992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical characteristics of patients with normotension in pheochromocytomas and paragangliomas.
    Zhao L; Zhang T; Meng X; Fan H; Zhang Z; Liu Y; Zhou X; Zhu H
    Endocrine; 2023 Apr; 80(1):174-182. PubMed ID: 36749542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatic IDH1 Hotspot Variants in Chinese Patients With Pheochromocytomas and Paragangliomas.
    Li M; He Y; Pang Y; Zhang J; Feng Y; He Y; Xu X; Wei Y; Zhong D; Deng W; Wang L; Yan B; Jiang Y; Xu N; Cai H; Wen Y; Ning J; Liu Y; Gao X; Shan Z; Liu L; Teng X; Richter S; Jiang J
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1215-1223. PubMed ID: 36355572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas.
    Al-Harthy M; Al-Harthy S; Al-Otieschan A; Velagapudi S; Alzahrani AS
    Endocr Pract; 2009 Apr; 15(3):194-202. PubMed ID: 19364686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs).
    Khatami F; Mohammadamoli M; Tavangar SM
    Endocr Regul; 2018 Jan; 52(1):41-54. PubMed ID: 29453919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromogranin A in a Cohort of Pheochromocytomas and Paragangliomas: Usefulness at Diagnosis and as an Early Biomarker of Recurrence.
    Parisien-La Salle S; Provençal M; Bourdeau I
    Endocr Pract; 2021 Apr; 27(4):318-325. PubMed ID: 33581325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations.
    Grigoryan S; Nhan W; Zhang L; Urban C; Zhao L; Turcu AF
    J Clin Endocrinol Metab; 2023 May; 108(6):e343-e349. PubMed ID: 36469797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Characteristics of Incidental Pheochromocytoma and Paraganglioma.
    Zhang J; Li M; Pang Y; Wang C; Wu J; Cheng Z; Li X; Lu Z; Liu Y; Guo J; Chen X; He Y; Guan X; Xu X; Wang Y; Liu J; Guo W; Hou Y; Liu L; Jiang J; Gao X
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1835-e1842. PubMed ID: 35106577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation Between Plasma Catecholamines, Weight, and Diabetes in Pheochromocytoma and Paraganglioma.
    Krumeich LN; Cucchiara AJ; Nathanson KL; Kelz RR; Fishbein L; Fraker DL; Roses RE; Cohen DL; Wachtel H
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4028-e4038. PubMed ID: 34089611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of [
    Takenaka J; Watanabe S; Abe T; Hirata K; Uchiyama Y; Kimura R; Shinohara N; Kudo K
    Ann Nucl Med; 2023 Jan; 37(1):10-17. PubMed ID: 36301465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension.
    Constantinescu G; Langton K; Conrad C; Amar L; Assié G; Gimenez-Roqueplo AP; Blanchard A; Larsen CK; Mulatero P; Williams TA; Prejbisz A; Fassnacht M; Bornstein S; Ceccato F; Fliedner S; Dennedy M; Peitzsch M; Sinnott R; Januszewicz A; Beuschlein F; Reincke M; Zennaro MC; Eisenhofer G; Deinum J
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3374-83. PubMed ID: 32609829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a novel nomogram predicting pseudohypoxia type pheochromocytomas and paragangliomas.
    Wang Y; Liu L; Chen D; Pang Y; Xu X; Liu J; Li M; Guan X
    J Endocrinol Invest; 2023 Jul; 46(7):1361-1371. PubMed ID: 36508127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s).
    van Heerden JA; Roland CF; Carney JA; Sheps SG; Grant CS
    World J Surg; 1990; 14(3):325-9. PubMed ID: 1973322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.